Cambridge, Mass.-based Metamark Genetics announced a new agreement with Anthem Blue Cross Blue Shield of Georgia Tuesday. The agreement, effective May 25, states Anthem BCBS will provide its customers ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics, Inc. (“Metamark”), a leader in developing and commercializing high-value urologic oncology products, today announced that it has entered into a ...
Cambridge, Mass.-based Metamark Genetics partnered with San Antonio-based Blue Cross Blue Shield of Texas, extending its urology diagnostics to policyholders. Metamark, a biotechnology company ...
Privately held Metamark Genetics Inc. landed a big fish, inking a research, collaboration and license agreement with Johnson & Johnson subsidiary Janssen Biotech Inc. potentially worth $365 million.
Firms will combine Prognostic Determinants assay technology with Definiens’ biomarker imaging platform. Cancer molecular diagnostics firm Metamark Genetics and cell imaging specialist Definiens signed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results